SS
EBS icon

SBI Securities’s Emergent Biosolutions EBS Stock Holding History

SBI Securities’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.4K Sell
4,818
-124
-3% -$1.04K ﹤0.01% 1249
2026
Q1 		$41K Sell
4,942
-1,417
-22% -$14.7K ﹤0.01% 1177
2025
Q4 		$78.6K Sell
6,359
-145
-2% -$1.55K ﹤0.01% 924
2025
Q3 		$57.4K Sell
6,504
-6,459
-50% -$50.2K ﹤0.01% 1033
2025
Q2 		$82.7K Buy
12,963
+12
+0.1% +$69 ﹤0.01% 880
2025
Q1 		$62.9K Buy
12,951
+6,313
+95% +$52.3K ﹤0.01% 899
2024
Q4 		$63.5K Buy
+6,638
New +$60.9K ﹤0.01% 904

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

SBI Securities's EBS Position: Q2 2026 in Review

SBI Securities reduced its Emergent Biosolutions (EBS) stake by 2.5% in Q2 2026, selling an estimated $1.04K and leaving 4,818 shares worth $40.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1249.

SBI Securities first reported a position in EBS in Q4 2024 and has held it in 7 quarters since. The position peaked at $82.7K in Q2 2025. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • SBI Securities held 4,818 shares of Emergent Biosolutions worth $40.4K as of Q2 2026.
  • SBI Securities sold 124 Emergent Biosolutions shares in Q2 2026, an estimated $1.04K.
  • Emergent Biosolutions made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1249 holding.
  • SBI Securities first reported a position in Emergent Biosolutions in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Emergent Biosolutions position peaked at $82.7K in Q2 2025.
  • 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.